Intermolecular (NASDAQ: IMI) is one of 105 public companies in the “Semiconductors” industry, but how does it compare to its rivals? We will compare Intermolecular to related businesses based on the strength of its analyst recommendations, valuation, profitability, dividends, institutional ownership, earnings and risk.

Analyst Recommendations

This is a summary of recent ratings and price targets for Intermolecular and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intermolecular 0 1 0 0 2.00
Intermolecular Competitors 903 4716 8622 359 2.58

As a group, “Semiconductors” companies have a potential upside of 11.97%. Given Intermolecular’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Intermolecular has less favorable growth aspects than its rivals.

Risk and Volatility

Intermolecular has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Intermolecular’s rivals have a beta of 1.07, indicating that their average share price is 7% more volatile than the S&P 500.

Insider & Institutional Ownership

38.0% of Intermolecular shares are owned by institutional investors. Comparatively, 67.0% of shares of all “Semiconductors” companies are owned by institutional investors. 45.4% of Intermolecular shares are owned by company insiders. Comparatively, 6.6% of shares of all “Semiconductors” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.


This table compares Intermolecular and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Intermolecular -47.22% -43.57% -35.71%
Intermolecular Competitors -47.37% -0.05% -0.13%

Valuation & Earnings

This table compares Intermolecular and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Intermolecular $39.08 million -$5.32 million -2.76
Intermolecular Competitors $4.58 billion $1.32 billion 85.99

Intermolecular’s rivals have higher revenue and earnings than Intermolecular. Intermolecular is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.


Intermolecular rivals beat Intermolecular on 10 of the 12 factors compared.

Intermolecular Company Profile

Intermolecular, Inc. provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems. It develops technology and Internet protocol (IP) rights focused on materials, processes, integration and device architectures in collaboration with its customers. Its HPC platform consists of tempus HPC processing, automated characterization and informatics and analysis software. The Company offers a series of wet processing tools and dry processing tools. Its informatics software includes workflow management software, analysis and reporting software, security and collaboration management software, and integration services. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies.

Receive News & Stock Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related stocks with our FREE daily email newsletter.